Mutant Variant Of Virus Detected, Active Cases Drop To 53,940

Active COVID-19 caseload across the nation has slightly dropped to 53,940 on Monday. The figure was 65,804 last week.
According to the Ministry of Health and Population (MoHP), among the active cases, 3,636 are admitted to various health facilities while remaining 50,304 patients are in home isolation.
As per the latest update, 811 COVID-19 patients are admitted to the Intensive Care Units (ICUs) and 237 are under treatment with ventilator support across the nation.
With 1,584 new confirmed cases today, the countrywide total COVID-19 tally has now reached 622,640 confirmed via PCR tests and another 27,308 from antigen tests. Also, 713 were tested positive for virus in the antigen tests done in the past 24 hours.
Nepal has now recorded 559,928 recoveries with 3,130 recovered in the last 24 hours. The recovery rate now stands at 89.9 per cent.
The country also reported 46 deaths related to COVID-19 in the past 24 hours, taking the total death toll to 8,772.
With 6,583 PCR-tests conducted in the past 24 hours, the total number of PRC tests has reached 3,275,849 till date. Likewise, 146,883 antigen tests have been performed till now, as per the MoHP.
According to the MoHP update on COVID vaccination, so far, 2,500,196 people have received the first dose of vaccine against COVID-19 across the country. Of them, 691,494 individuals have been inoculated with both the doses and are fully vaccinated.
The Delta variant’s mutation of the COVID-19 has been detected in Nepal. According to the Ministry of Health and Population (MoHP), the mutated forms of the Delta variant were confirmed in nine samples while conducting gene sequencing in New Delhi, India.
Issuing a press statement, deputy spokesperson at the MoHP Dr. Samir Kumar Adhikari informed that among the 47 Delta variant confirmed during the gene sequencing, nine new K417 N mutation were detected which has been named AY.1 .
This new mutation has been detected in 10 countries including Nepal so far and is considered more infectious and fatal to the people of all age groups, according to the MoHP.
Earlier, Nepal had sent 48 swab samples to the WHO-identified Centre for Excellence in Genomics, The Institute of Genomics and Integrative Biology (IGIB) in New Delhi, India, for testing.

Source : TRN,